**
A growing number of individuals in the UK are grappling with debilitating skin conditions linked to the withdrawal from topical steroid treatments, raising urgent questions about diagnosis, treatment, and the overall efficacy of these commonly prescribed medications. The phenomenon, known as Topical Steroid Withdrawal (TSW), has gained significant traction on social media platforms, highlighting the often-overlooked struggles faced by many patients.
The Burden of Misdiagnosis
Bethany Gamble, a 21-year-old from Birmingham, has lived with eczema since childhood and initially found relief through steroid creams. However, her condition took a severe turn at 18. “My skin was hot, inflamed, and red. It began to crack and ooze, and the itch was bone-deep,” she recalls. The debilitating symptoms consumed her life, rendering her unable to perform daily activities and forcing her mother to take time off work to care for her.
Despite her escalating symptoms, Gamble felt dismissed by medical professionals. “I was constantly gaslit by doctors. They kept telling me it was just my eczema and offering me more steroids. I’ve had eczema my whole life—this was different.” Her experience mirrors that of many others who describe a lack of understanding and recognition from healthcare providers regarding TSW.
Social Media as a Catalyst for Change
The hashtag #TSW has emerged as a powerful tool on platforms like TikTok, with videos related to topical steroid withdrawal accumulating over a billion views. This online movement has brought together countless individuals documenting their experiences with red, inflamed, and peeling skin. The visibility of these accounts has catalysed research efforts, with experts like Professor Sara Brown from the University of Edinburgh stepping forward to investigate the condition that remains largely unrecognised within the medical community.
“Symptoms like thickening and laxity of the skin, so-called ‘elephant skin’, extreme shedding, and sharply defined areas of redness next to normal skin cannot be explained by existing knowledge of eczema,” Brown states. Her research aims to unravel the complexities surrounding TSW, focusing on understanding why it affects some individuals and not others.
The Plight of Patients
Henry Jones, a 22-year-old from High Wycombe, is among those participating in the study. Once a casual user of steroid creams for his eczema, he now identifies as a “TSW warrior” determined to raise awareness. His symptoms escalated to the point where he had to withdraw from his university course. “My GP kept telling me it was just eczema and prescribed more steroid cream. The more I applied, the worse I felt,” he explains.
Jones describes a harrowing cycle of symptoms: tight, red skin that flaked and oozed. The condition led to profound social isolation and, at times, thoughts of self-harm. He expresses the emotional toll of living with TSW, stating, “My world became a dark hole caused by the weight of my skin.”
Similarly, Karishma Leckraz, 32, from Kent, faced years of denial, believing her symptoms could not be related to TSW because they appeared differently on her brown skin. “TSW took everything away from me. I had to hide from the world for so long,” she says. After stopping steroid use five years ago, she has seen some improvement, but the psychological scars remain.
The Need for Comprehensive Treatment Options
Despite the challenges posed by TSW, experts acknowledge that steroid creams remain effective for many. Andrew Procter from the National Eczema Society notes the dilemma patients find themselves in: “Patients are stuck between a rock and a hard place. We know that steroids work for the many millions who use them, but we also have a condition that cannot be explained, which is causing real fear.”
For those suffering from TSW, the road to treatment can be fraught with obstacles, including lengthy wait times for specialist dermatology appointments. At the Royal London Hospital, Dr Alia Ahmed runs a clinic dedicated to chronic skin diseases, offering various treatment options, including psychological support and immunosuppressants. “The psychological impact, as well as the physical effects, is huge,” she emphasises, highlighting the necessity of a tailored approach to patient care.
The Medicines and Health Regulatory Authority (MHRA) officially recognised TSW as a severe reaction to topical steroids in 2021, though it remains classified as a relatively rare condition. The agency warns of potential side effects associated with prolonged steroid use, including skin thinning and adrenal suppression.
Patients like Rebecca Ebbage, 32, have experienced the drastic effects of TSW firsthand. Her skin has dictated her life choices, from what she can wear to whether she can socialise. After a year-long wait for a dermatology appointment, she sought private treatment for her symptoms, which included Cold Atmospheric Plasma (CAP) therapy, a relatively new and unregulated treatment option.
Why it Matters
The plight of those suffering from TSW underscores a critical gap in our understanding of topical steroid use and its potential consequences. As patients continue to share their experiences, the call for increased research and comprehensive treatment options grows louder. The intersection of mental and physical health in the context of chronic skin conditions necessitates urgent attention from healthcare professionals and policymakers alike. Addressing this hidden crisis is not just a matter of improving treatment protocols; it is about acknowledging patient experiences and fostering a healthcare environment where their voices are heard and validated.
